229 results on '"Warnecke, G"'
Search Results
2. Association of Higher CD4+CD25highCD127low, FoxP3+, and IL-2+ T Cell Frequencies Early After Lung Transplantation With Less Chronic Lung Allograft Dysfunction at Two Years
3. Everolimus Versus Mycophenolate Mofetil De Novo After Lung Transplantation: A Prospective, Randomized, Open-Label Trial
4. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients
5. Prolonged Mechanical Ventilation After Lung Transplantation—A Single-Center Study
6. Augmentation of Transient Donor Cell Chimerism and Alloantigen-Specific Regulation of Lung Transplants in Miniature Swine
7. Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study
8. Paclitaxel-Coated Balloons in Refractory Nonanastomostic Airway Stenosis Following Lung Transplantation
9. Phenotyping Established Chronic Lung Allograft Dysfunction Predicts Extracorporeal Photopheresis Response in Lung Transplant Patients
10. Adaptive space and time numerical simulation of reaction–diffusion models for intracellular calcium dynamics
11. Robust a posteriori error estimates for subgrid stabilization of non-stationary convection dominated diffusive transport
12. (875) - Does Cytokine Adsorption Improve Postoperative Course in Orthotopic Heart Transplantation?
13. (657) - Longitudinal Dynamics of the NK Cell Repertoire After Lung Transplantation and Their Potential Role for Control in CMV Reactivation
14. (191) - Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass
15. Calcium Domains around Single and Clustered IP 3 Receptors and Their Modulation by Buffers
16. Modeling of the Modulation by Buffers of Ca2+ Release through Clusters of IP3 Receptors
17. Hybrid Stochastic and Deterministic Simulations of Calcium Blips
18. (1264) Recipients of Extended Criteria Ex Situ Preserved Lungs Display Higher Plasma Levels of Cytokines and Endothelial Markers after Lung Transplantation Without Higher PGD Scores
19. (410) Perioperative Desensitization Changes the Plasma Cytokine Milieu in Lung Transplant Patients with Preformed Donor Specific Antibodies
20. (402) 12-Year Experience with Postoperatively Extended Intraoperative Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Severe Pulmonary Arterial Hypertension
21. (120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience
22. (101) Nine-Year Experience with Treatment of Early Detectable Donor Specific Anti-HLA Antibodies in Pediatric Lung Transplant Recipients
23. Influence of Tricuspid Regurgitation After Heart Transplantation: A 10-Year Single Center Experience
24. Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?
25. Lung Transplant Recipients Developing Early DSAs within the First Month Are Characterized by a Higher Frequency of Naïve and a Lower Frequency of Memory B Cells
26. Results of Temporary Right Heart Assist Device Implantation Following Right Heart Failure
27. How to Heal a Broken Heart with Time and a Hybrid Mechanical Circulatory Support Armada
28. Adverse Events in HVAD vs. HM3 Patients under Outpatient Bridging with Low-Molecular Weight Heparin for Subtherapeutic Anticoagulation
29. Primary Graft Dysfunction Following Lung Transplantation is Associated with Increased In Vivo T Cell Alloreactivity: Evidence from a Humanized Mouse Model
30. Lung Transplantation and Concomitant Coronary Artery Bypass Grafting Does Not Impair Patient Outcomes: Insights from a Single-Center Experience
31. Perioperative Desensitization with IgA- and IgM-Enriched Human Immunoglobulins Allows Safe Lung Transplantation in Patients with Preformed Donor Specific Antibodies
32. Risk Factors for the Development of Early Anti-HLA Donor Specific Antibodies After Lung Transplantation: The Role of Primary Graft Dysfunction
33. Eight-Year Results of an IgA- and IgM-Enriched Human Immunoglobulin-Based Therapy for Early Detectable Anti-HLA Donor Specific Antibodies After Lung Transplantation
34. Liver-First Strategy for Combined Lung and Liver Transplantation: 15-Year Single-Center Experience
35. Full Recovery of Right Ventricular Systolic Function in Children Undergoing Bilateral Lung Transplantation for Severe PAH
36. Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate into the Periphery of Lung Transplant Recipients - A Potential Feature for Tolerance Development
37. Long-Term Results of the OCS Lung Expand International Trial Using Organ Care System Lung Perfusion System (OCS) in Extended-Criteria Donor (ECD) and Donation After Circulatory Death (DCD) Donor Lungs
38. Finite Volume Evolution Galerkin Methods for Nonlinear Hyperbolic Systems
39. Impact of Donor Quality on Recipient Outcomes in Lung Transplantation: 10-year Single-Center Experience Using the Eurotransplant Lung Donor Score
40. Interim Results - The Effect of Donor Type (Donor after Cardiac Death vs Donor after Brain Death) and Use of Intraoperative Extracorporeal Lung Support on Survival after Lung Transplantation
41. Impact of Cold Ischemic Time on Morbidity and Mortality after Lung Transplantation. An Updated Analysis of the International Multicenter Extracorporeal Life Support in Lung Transplantation Registry
42. Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate into the Periphery of Lung Transplant Recipients - A Potential Feature for Tolerance Development
43. A Transplanted Broken Heart Healed with Time and Temporary Mechanical Circulatory Support
44. From Heart Failure via Biventricular Assist Device to Heart Transplantation
45. Seven-Year Clinical Results of an IgA-and IgM-Enriched Human Immunoglobulin-Based Therapy for Antibody-Mediated Rejection after Lung Transplantation
46. Preformed Donor Specific Antibodies in Lung Transplantation - Perioperative Desensitization Using IgA- and IgM-Enriched Immunoglobulins
47. Fifteen-Year Single Center Experience with Lung Transplantation in Pediatric Patients Younger Than 12 Years Old
48. Regulatory T Cells and the Effect of Ex Vivo Preservation on the Development of Transplant Arteriosclerosis in a Humanized Mouse Model
49. 10-Year Experience with Postoperatively-Extended Intraoperative Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Severe Pulmonary Hypertension
50. Influence of Donor-Recipient Age Mismatch in Young Lung Transplant Recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.